The Biosim•Exchange: Canada’s trusted source for timely information on biosimilar biologics

As Canada’s leading arthritis patient voice, Arthritis Consumer Experts (ACE) has created a reader-friendly information hub for consumers to get the latest biosimilar biologics ("biosimilars") news and background analysis through the Biosim•Exchange.

The Biosim•Exchange provides research-based information on biosimilar safety and effectiveness and reports on public and private health insurance formulary policy or listing decisions.

Our aim with the timely delivery of biosimilars information is to help patients better understand biosimilars and learn about their place among other inflammatory arthritis treatments. Armed with this knowledge, patients and their physicians can build stronger partnerships leading to improved shared decision-making and treatment plan results.

Please share the Biosim•Exchange with other patients, your friends and family.

We look forward to your questions and comments and hearing about your experience with biosimilars.